33 related articles for article (PubMed ID: 18691650)
1. Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersion with TPGS 1000 and Eudragit E100.
Goddeeris C; Willems T; Houthoofd K; Martens JA; Van den Mooter G
Eur J Pharm Biopharm; 2008 Nov; 70(3):861-8. PubMed ID: 18691650
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Matrix Tablets Based on Eudragit®E100/Carbopol®971P Combinations for Controlled Release and Improved Compaction Properties of Water Soluble Model Drug Paracetamol.
Obeidat WM; Nokhodchi A; Alkhatib H
AAPS PharmSciTech; 2015 Oct; 16(5):1169-79. PubMed ID: 25724162
[TBL] [Abstract][Full Text] [Related]
3. Indinavir-loaded pH-sensitive microparticles for taste masking: toward extemporaneous pediatric anti-HIV/AIDS liquid formulations with improved patient compliance.
Chiappetta DA; Carcaboso AM; Bregni C; Rubio M; Bramuglia G; Sosnik A
AAPS PharmSciTech; 2009; 10(1):1-6. PubMed ID: 19127436
[TBL] [Abstract][Full Text] [Related]
4. Engineering pH-sensitive dissolution of lipid-polymer nanoparticles by Eudragit integration impacts plasmid DNA (pDNA) transfection.
Santhanes D; Zhang H; Wilkins A; John Aitken R; Gannon AL; Liang M
Eur J Pharm Biopharm; 2024 Jun; 199():114299. PubMed ID: 38643953
[TBL] [Abstract][Full Text] [Related]
5. Solid dispersion systems for enhanced dissolution of poorly water-soluble candesartan cilexetil: In vitro evaluation and simulated pharmacokinetics studies.
Ali ISM; Sajad UA; Abdul Rasool BK
PLoS One; 2024; 19(6):e0303900. PubMed ID: 38843120
[TBL] [Abstract][Full Text] [Related]
6. "Nok": a phytosterol-based amphiphile enabling transition-metal-catalyzed couplings in water at room temperature.
Klumphu P; Lipshutz BH
J Org Chem; 2014 Feb; 79(3):888-900. PubMed ID: 24447127
[TBL] [Abstract][Full Text] [Related]
7. TPGS-750-M: a second-generation amphiphile for metal-catalyzed cross-couplings in water at room temperature.
Lipshutz BH; Ghorai S; Abela AR; Moser R; Nishikata T; Duplais C; Krasovskiy A; Gaston RD; Gadwood RC
J Org Chem; 2011 Jun; 76(11):4379-91. PubMed ID: 21548658
[TBL] [Abstract][Full Text] [Related]
8. Effect of talc and vitamin E TPGS on manufacturability, stability and release properties of trilaurin-based formulations for hot-melt coating.
Huynh VT; de Paiva Lacerda S; Espitalier F; Beyssac E; Ré MI
Int J Pharm; 2024 Mar; 653():123866. PubMed ID: 38286194
[TBL] [Abstract][Full Text] [Related]
9. Using Polymers as Crystal Inhibitors to Prevent the Crystallization of the Rotigotine Patch.
Liu Q; Li X; Liu B; Kong J; Wang Q; Gao Z
Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794291
[TBL] [Abstract][Full Text] [Related]
10. Influence of Molecular Structure and Physicochemical Properties of Immunosuppressive Drugs on Micelle Formulation Characteristics and Cutaneous Delivery.
Quartier J; Lapteva M; Boulaguiem Y; Guerrier S; Kalia YN
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111763
[TBL] [Abstract][Full Text] [Related]
11. Increasing Cellular Uptake and Permeation of Curcumin Using a Novel Polymer-Surfactant Formulation.
Liu Z; Lansley AB; Duong TN; Smart JD; Pannala AS
Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551167
[TBL] [Abstract][Full Text] [Related]
12. Drug crystal growth in ternary amorphous solid dispersions: Effect of surfactants and polymeric matrix-carriers.
Kapourani A; Tzakri T; Valkanioti V; Kontogiannopoulos KN; Barmpalexis P
Int J Pharm X; 2021 Dec; 3():100086. PubMed ID: 34151251
[TBL] [Abstract][Full Text] [Related]
13. Development of Apremilast Solid Dispersion Using TPGS and PVPVA with Enhanced Solubility and Bioavailability.
Yang L; Wu P; Xu J; Xie D; Wang Z; Wang Q; Chen Y; Li CH; Zhang J; Chen H; Quan G
AAPS PharmSciTech; 2021 Apr; 22(4):142. PubMed ID: 33893566
[TBL] [Abstract][Full Text] [Related]
14. Unravelling the Miscibility of Poly(2-oxazoline)s: A Novel Polymer Class for the Formulation of Amorphous Solid Dispersions.
Everaerts M; Tigrine A; de la Rosa VR; Hoogenboom R; Adriaensens P; Clasen C; Van den Mooter G
Molecules; 2020 Aug; 25(16):. PubMed ID: 32781768
[TBL] [Abstract][Full Text] [Related]
15. Spray-Dried Amorphous Solid Dispersions of Griseofulvin in HPC/Soluplus/SDS: Elucidating the Multifaceted Impact of SDS as a Minor Component.
Rahman M; Ahmad S; Tarabokija J; Parker N; Bilgili E
Pharmaceutics; 2020 Feb; 12(3):. PubMed ID: 32106495
[TBL] [Abstract][Full Text] [Related]
16. New Perspectives for Fixed Dose Combinations of Poorly Water-Soluble Compounds: a Case Study with Ezetimibe and Lovastatin.
Riekes MK; Engelen A; Appeltans B; Rombaut P; Stulzer HK; Van den Mooter G
Pharm Res; 2016 May; 33(5):1259-75. PubMed ID: 26857899
[TBL] [Abstract][Full Text] [Related]
17. Assessing Mixing Quality of a Copovidone-TPGS Hot Melt Extrusion Process with Atomic Force Microscopy and Differential Scanning Calorimetry.
Lamm MS; DiNunzio J; Khawaja NN; Crocker LS; Pecora A
AAPS PharmSciTech; 2016 Feb; 17(1):89-98. PubMed ID: 26283196
[TBL] [Abstract][Full Text] [Related]
18. Formulation and Pharmacokinetic Evaluation of Polymeric Dispersions Containing Valsartan.
Chella N; Daravath B; Kumar D; Tadikonda RR
Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):517-26. PubMed ID: 26156887
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of solid dispersion for dissolution improvement of furosemide by cogrinding method.
Siahi-Shadbad MR; Ghanbarzadeh S; Barzegar-Jalali M; Valizadeh H; Taherpoor A; Mohammadi G; Barzegar-Jalali A; Adibkia K
Adv Pharm Bull; 2014 Dec; 4(4):391-9. PubMed ID: 25436197
[TBL] [Abstract][Full Text] [Related]
20. pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission.
Zhang T; Sturgis TF; Youan BB
Eur J Pharm Biopharm; 2011 Nov; 79(3):526-36. PubMed ID: 21736940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
